Drug Provides Better Kidney Transplant Survival Rates Than Current Standard of Care
University of California, San Francisco (UCSF)For the first time, an immunosuppressive agent has shown better organ survival in kidney transplant recipients than a calcineurin inhibitor, the current standard of care, according to a worldwide study led by UC San Francisco and Emory University investigators.